Clinical trial
Long-Term Outcome in Offspring and Mothers of Dexamethasone-Treated Pregnancies at Risk for Classical Congenital Adrenal Hyperplasia Owing to 21-Hydroxylase Deficiency
NCT00617292 is registered in ClinicalTrials.gov with Office of Rare Diseases (ORD) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-Term Outcome in Offspring and Mothers of Dexamethasone-Treated Pregnancies at Risk for Classical Congenital Adrenal Hyperplasia Owing to 21-Hydroxylase Deficiency
- Lead sponsor
- Office of Rare Diseases (ORD)
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 31, 2008
- Completion date
- July 31, 2009
- Enrollment
- 233 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.